Zhong Yuan Bio-Technology Holdings Limited (ZHYBF)

Zhong Yuan Bio-Technology Holdings Limited (ZHYBF) — VMCI valuation read

The headline on Zhong Yuan Bio-Technology Holdings Limited (ZHYBF) is a 38/100 VMCI score, set against a Consumer Defensive sector median of 50. That 12-point below-median read reflects the five-pillar weighting and, for a mid-cap name, suggests a relative-value drag is in the data.

ZHYBF insider activity report: 0 buys, 0 sells filed via Form 4 over the past 30 days. The next datable items are the 10-Q schedule and any 8-K-triggering events; both feed the VMCI Integrity pillar more than the price tape.

**Investor frame.** ZHYBF trades at 23.0x earnings, 28% above the Consumer Defensive median of 18.0x sets the value side. ROIC of 15.0% sits 5.0pp above the Consumer Defensive median (10.0%) sets the quality side. Net debt to EBITDA of 3.2x is the binding constraint on the bear case sets the risk side, the three lines a value buyer reads first on ZHYBF.

ZHYBF fell 2.2% over the trailing 7 days, with a +7.0% read on a 30-day basis.